Login
Cart
Support
Search
Search
Search
Federico Aucejo
Cleveland Clinic
Appearances
View Grid
IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA, A SINGLE CENTER EXPERIENCE.
Date
May 9, 2023
Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Roma Raj
Speakers
Nihal Aykun
Chase Wehrle
Marianna Maspero
Bassam Estfan
Suneel Kamath
Smitha Krishnamurthi
Federico Aucejo
Cleveland Clinic
SSAT Oral Session: Hepatobiliary Tract Diseases
Date
May 9, 2023
SOCIETY: SSAT
Moderators
Federico Aucejo
Cleveland Clinic
Yoshikuni Kawaguchi
The University of Tokyo
Natalia Paez Arango
The University of Texas MD Anderson Cancer Center
NEOADJUVANT THERAPY REDUCES NODE POSITIVITY BUT DOES NOT CONFER SURVIVAL BENEFIT VERSUS UP-FRONT RESECTION FOR RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA: A PROPENSITY-MATCHED ANALYSIS
Date
May 21, 2024
Intrahepatic Cholangiocarcinoma (iCCA) is rare but deadly. Neoadjuvant systemic therapy (NAST) is frequently employed, though its’ impact on short-term oncologic outcomes and/or survival remains relatively unknown…
Presenter
Chase Wehrle
Speakers
Jenny Chang
Kimberly Woo
Abby Gross
Robert Naples
Kathryn Stackhouse
Jaekeun Kim
Toms Augustin
Cleveland Clinic
Robert Simon
Daniel Joyce
Choon Hyuck David Kwon
R Matthew Walsh
Cleveland Clinic
Federico Aucejo
Cleveland Clinic
Samer Naffouje